Barnaby Page || 25th May 2016 || News analysis || Companies | Regulation and Legislation | Geographies: North America United States
E-liquid maker Lost Art Liquids has filed suit against the U.S. Food and Drug Administration (FDA), claiming that the deeming regulations violate two parts of the U.S. Constitution and two important statutes.
Are you already a subscriber? login here Enjoy free subscription access Get access to premium content that is normally only available for subscribers. For the duration of a week, you can read our news analysis, identify market trends and understand upcoming changes in the industry, which will enable you to get ahead of your competitors. Benefits of subscription plans: Stay informed of any legal and market change in the sector that impacts your organization Maximise resources by getting market and legal data analysis daily in one place Make smart decisions by understanding how the regulatory and market landscape evolves Anticipate risks in your decisions by monitoring regulatory changes that impact your organization